share_log

BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded

BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded

简报-华北制药称单位反垄断案重新审理
reuters ·  2021/11/08 17:46

Nov 8 (Reuters) - North China Pharmaceutical Co LTd

路透11月8日电-华北制药有限公司

600812.SS :

600812.SS:

* SAYS UNIT'S ANTI-MONOPOLY CASE HAS BEEN RECINDED BY U.S. COURT IN NEW YORK

*表示单位的反垄断案件已被纽约美国法院重新审理

Source text Further company coverage: 600812.SS

源文本进一步公司报道:600812.SS

(Reporting by Hong Kong newsroom)

(香港新闻编辑部报道)

((meg.shen@thomsonreuters.com; 852-39525805;))

(meg.shen@thomsonreurs.com;852-39525805;)

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发